News in Numbers
$750m
The investment management company Blackstone has committed to provide $750m to support Moderna’s influenza program.
45%
As per the World Health Organization, the hepatitis B birth-dose coverage is at 45% on a global level.
$1.1bn
Novo Nordisk is spending $1.1bn in upfront and milestone-based payments to acquire the German company Cardior Pharmaceuticals.
64
As per the US Centres for Disease Control and Prevention, there have been 64 documented cases of measles in 2024, which is higher than the total number of cases noted in 2023.
$47,400
The high-profile US Food and Drug Administration (FDA) approval of Madrigal Pharmaceuticals’ Rezdiffra (resmetirom) for treating noncirrhotic nonalcoholic steatohepatitis (NASH), was followed by the announcement that it will have a list price of $47,400 for an annual supply.
